Connect with us

%

Researchers Report Promising Progress Toward Oral Insulin Treatment

Published

on

researchers-report-promising-progress-toward-oral-insulin-treatment

The ability to take a pill instead of injecting could simplify treatment regimens, reduce needle‑associated anxiety and improve overall adherence to therapy. Photo credit: ElenaYakimova/Shutterstock

Researchers in Japan have reported a significant step in the long‑standing scientific effort to develop an insulin medication that can be taken orally rather than by injection. The work, conducted at Kumamoto University, employed innovative delivery techniques that allowed insulin to survive the digestive process and enter the bloodstream in animal tests. 

For more than a century, scientists have sought a way to administer insulin without needles, recognising that injections pose practical and psychological challenges for people who require regular insulin therapy. Insulin was first discovered in the early 1920s and quickly transformed diabetes from a fatal condition to a manageable one. However, the digestive system’s natural processes have consistently broken down insulin molecules when taken by mouth, making oral delivery extremely difficult. 

Novel Peptide Approach Shows Promise

The Japanese research team developed a platform using a cyclic peptide known as DNP as a carrier to protect insulin from degradation in the gastrointestinal tract and help it cross the intestinal wall into the bloodstream. Two different methods were tested in animal models. In one approach, a modified form of the DNP peptide was mixed with zinc‑stabilised insulin molecules. In the other, the peptide was directly attached to the insulin protein. Both methods resulted in reduced blood glucose levels in the test animals. 

The reported pharmacological bioavailability achieved through these techniques was between 33 per cent and 41 per cent compared with traditional injections, a figure that significantly exceeds previous attempts at oral insulin. The term “bioavailability” refers to the proportion of the administered dose that reaches the systemic circulation and is available to exert a therapeutic effect. Achieving even a third of the effectiveness of injections through oral administration marks a new benchmark in this area of research. 

While these results are confined to preclinical studies, the team says the findings open a promising pathway for not only insulin but possibly other biological medicines that are currently only available through injection. 

Historical Challenges in Oral Insulin Development

The barriers to oral insulin have been well documented in scientific literature. Insulin is a large protein that is readily broken down by enzymes in the stomach and intestine, and the lining of the gut presents a further obstacle to absorption into the bloodstream. These physiological features make simple oral administration ineffective without significant technological intervention. 

A literature review on oral insulin delivery highlights these challenges and notes that researchers have tested multiple strategies, including permeation enhancers, protective coatings and various carrier molecules, but none has yet produced a clinically approved product that reliably delivers insulin via the oral route. 

The current work builds on decades of research by demonstrating a specific peptide that can assist insulin’s passage across the intestinal epithelium. This is widely regarded as one of the most durable barriers to effective oral delivery of proteins like insulin. 

Implications for Patients

If successfully translated to human use, oral insulin could change the daily lives of people with diabetes, particularly those with type 1 diabetes who must administer insulin many times each day. The ability to take a pill instead of injecting could simplify treatment regimens, reduce needle‑associated anxiety and improve overall adherence to therapy. 

Oral administration also aligns more closely with the natural physiology of insulin release. In people without diabetes, pancreatic insulin enters the liver directly from the bloodstream, and this first‑pass effect is considered beneficial for glucose regulation. Although research into oral insulin aims to mimic this pathway, replicating it in humans remains a complex task that requires further study. 

Next Steps and Remaining Hurdles

Despite the encouraging preclinical results, there are clear steps before this science can become a treatment available to patients. The next phases would generally include larger animal studies to verify safety and efficacy in systems closer to humans, followed by carefully designed human clinical trials. These trials must establish not only that the drug lowers blood glucose effectively but also that it does so safely across diverse patient groups. 

Researchers caution that laboratory and animal results do not always translate directly into successful human treatments. As with all biomedical innovations, unexpected issues can emerge when a therapy is tested in people. Moreover, understanding how the peptide‑based delivery system behaves in the human gut, which differs from that of laboratory animals, will be vital in assessing the feasibility of this approach. 

Broader Context of Diabetes Management

Diabetes remains a global health challenge. Millions of people worldwide live with the condition, which, if not well controlled, can lead to a range of serious complications, including heart disease, kidney failure and vision loss. Insulin therapy is a cornerstone of treatment for many patients, and ongoing improvements in how it is delivered remain a significant priority for medical research. 

Other innovations in diabetes treatment, including new forms of weekly insulin injections for type 2 diabetes, illustrate the broader landscape of progress in managing the condition. These advancements reflect continuing efforts to improve convenience, treatment outcomes and quality of life for those affected. 

Conclusion

The recent findings from Japan are a meaningful step toward achieving a long‑held objective in diabetes care: a reliable oral form of insulin. While the work remains at an early stage and human application is not yet established, the demonstrated improvements in bioavailability and glucose control in animal models represent clear scientific progress. Future research will determine whether this approach can be adapted into an effective therapy for people living with diabetes

%

UK Cigarette Ban Creates Spain Loophole For British Teens

Published

on

uk-cigarette-ban-creates-spain-loophole-for-british-teens

Spain continues to use a standard minimum-age approach. Photo credit: Christian Bertrand

The United Kingdom’s planned lifetime tobacco sales ban for people born on or after January 1 2009 could create a loophole for young British teens travelling to Spain and other countries, as they may still be able to purchase cigarettes and vaping products where standard age-based rules remain in place.

The policy restricts tobacco sales based on year of birth, meaning those affected would never be eligible to buy cigarettes from UK retailers. Outside the UK, however, access is determined by national age limits rather than generational rules, creating a clear contrast for those travelling abroad.

Different rules in Spain

In Spain, tobacco sales are regulated through a standard minimum-age system, with purchase generally permitted from 18 years old. Eligibility is based solely on age at the point of sale, rather than year of birth or membership of a specific generation.

Tobacco products are widely available through regulated retail outlets across the country, including supermarkets, kiosks and licensed shops. Sales are subject to identity checks where age is unclear, particularly in urban and tourist-heavy areas where enforcement is more visible.

Travel-related differences

Spain is one of the most frequently visited destinations for UK travellers, with millions of trips each year for tourism, work and study. This makes it a common setting where differences in national consumer rules become visible in practice. For those affected by the UK policy, experiences abroad would depend on local regulations.

In Spain, access to regulated products would be governed by local age verification at the point of purchase. This means availability is shaped by Spanish law rather than any UK restriction, and enforcement is handled entirely by Spanish authorities and retailers. In practice, this creates situations where legal access to tobacco products may differ depending on location, particularly in busy tourist areas where international visitors form a significant proportion of customers.

Could the policy lead to tobacco tourism

The difference between UK and overseas rules has raised the possibility of a form of “tobacco tourism”, where individuals affected by the ban access products while travelling rather than at home. Because the UK restriction is based on year of birth, those in the affected group would never be able to legally buy tobacco domestically, even as adults.

In countries such as Spain, where access is determined by a standard minimum age of 18, the same individuals could legally purchase tobacco once they meet local age requirements. This creates a situation where availability depends entirely on location.

In practice, any such behaviour is likely to be limited and linked to existing travel rather than people making dedicated trips solely to buy tobacco. However, the contrast may be more visible in popular holiday destinations and border regions, where differences in national rules are easier to navigate.

Gibraltar border factor

The issue may also be particularly relevant in Gibraltar, where residents can cross directly into Spain within minutes. If Gibraltar applies UK-aligned restrictions, individuals affected by the 2009 cohort rule could potentially be unable to purchase tobacco locally while still being able to do so across the border in Spain, subject to Spanish law.

That would not change domestic restrictions in either territory, but it could create a practical cross-border difference for residents living near the frontier. Vaping regulations may also differ depending on how each jurisdiction chooses to regulate nicotine products, as tobacco and vape policies are not always aligned across borders. This means access to different products could vary even within short travel distances.

Cross-border policy contrast

The UK and Spain operate different tobacco regulatory systems, with the UK moving towards a generational restriction based on date of birth, while Spain continues to use a standard minimum-age approach.

This creates a policy divergence between a cohort-based restriction and an age-based system. It also means that eligibility rules are structured differently depending on whether the focus is long-term population prevention or immediate age compliance at point of sale. As a result, the experience of future adults affected by the UK measure may differ depending on whether they remain in the UK or travel abroad, particularly within Europe where cross-border movement is relatively straightforward.

Broader implications

The contrast has prompted discussion about how national public health policies interact with international mobility. While domestic restrictions apply within a country’s borders, access to tobacco remains dependent on local law.

This raises questions about consistency in regulation when citizens move between jurisdictions with different frameworks for controlling the same products. Critics point to inconsistencies that arise when individuals face different legal conditions depending solely on geography.

At the same time, supporters argue that national governments retain the right to set domestic health policy independently, even if outcomes differ abroad.

Outlook

As implementation of the UK policy progresses, attention is likely to focus on how the affected generation experiences differences in access during travel.

In Spain, where tobacco remains widely available under conventional age rules, the contrast with UK restrictions is expected to be most visible among young British adults once they reach legal purchasing age abroad. Over time, the practical effect of these differences may become clearer as the first cohort impacted by the UK measure begins travelling internationally as adults.

Continue Reading

%

UK Approves Lifetime Tobacco Ban For Everyone Born After 2008

Published

on

uk-approves-lifetime-tobacco-ban-for-everyone-born-after-2008

The policy is intended to reduce the number of people who start smoking at a young age. Photo credit: Richard Bradford/Shutterstock

The United Kingdom is set to introduce a permanent ban on the sale of tobacco to everyone born on or after  January 1 2009, after Parliament approved one of the most significant anti-smoking measures in recent decades. The proposal is contained in the Tobacco and Vapes Bill, which has passed both the House of Commons and the House of Lords. The legislation is now awaiting Royal Assent, the final formal stage before becoming law.

If enacted, the measure will not ban smoking itself. Instead, it will make it unlawful for retailers to sell tobacco products to anyone in the affected age group at any point in their lives.

How the system will work

Rather than setting a single new minimum age, the law creates a rolling age limit that increases each year. At present, the legal age for buying tobacco in the UK is 18. Under the new system, that threshold will continue to rise by one year annually for those born from 2009 onwards.

This means adults who can already legally buy tobacco will keep that right. However, someone born in 2009 or later would never reach an age at which tobacco sales become lawful for them. The policy applies to cigarettes and other tobacco products covered by existing age-of-sale laws.

Parliamentary approval

The bill has been debated over several stages in both Houses of Parliament. Supporters argued that smoking remains one of the leading causes of preventable illness and death, while opponents raised questions about enforcement, personal choice and the long-term practicality of a generational sales ban.

Despite those objections, the legislation secured enough support to pass through both chambers.

Once Royal Assent is granted, ministers will be able to bring the new rules into force through secondary legislation and implementation guidance.

Why the government is introducing it

The policy is intended to reduce the number of people who start smoking at a young age and lower long-term demand for tobacco. Successive governments have sought to reduce smoking rates through taxation, advertising restrictions, standardised packaging, public health campaigns and indoor smoking bans.

The new measure goes further by attempting to prevent future generations from legally accessing tobacco products at all.Ministers have described the policy as part of a long-term public health strategy aimed at reducing smoking-related disease and pressure on health services.

What it means for retailers

Shops that sell tobacco will need to continue checking ages, but over time the system will become more complex because the legal age will no longer be fixed at 18.

Instead, eligibility will depend on a customer’s date of birth. Retailers are expected to receive updated guidance on age verification and enforcement once the law is formally enacted. Existing penalties for unlawful tobacco sales may also apply to businesses that breach the new rules.

Wider measures in the bill

The legislation also includes powers to regulate vaping and nicotine products. These provisions allow ministers to introduce future rules covering areas such as flavours, packaging, product displays and restrictions in certain public places. Specific measures would require further regulations before taking effect.

The inclusion of vaping controls reflects concern among policymakers about youth uptake of nicotine products, even as vaping is also used by some adults as an alternative to smoking.

Public debate

The proposal has attracted support from many health organisations, which argue that preventing young people from starting to smoke is more effective than trying to help established smokers quit later in life.

Critics, however, have questioned whether the law creates different rights for adults based solely on year of birth. Others have argued that enforcement may become harder over time if legal and illegal age groups exist side by side. There has also been debate over whether restrictions on legal sales could increase the illicit tobacco market, though the long-term effect remains uncertain.

International significance

The UK is among the first major countries to legislate for a permanent generational ban on tobacco sales. Similar proposals have been discussed elsewhere, but few have advanced as far through the legislative process.

Public health campaigners are likely to watch implementation closely, particularly whether the measure leads to lower smoking uptake among younger age groups.

What happens next

The final step is Royal Assent, after which the bill will become law. The government will then set commencement dates and publish enforcement details.

If implemented as planned, people born on or after 1 January 2009 will never be able to legally buy tobacco in the United Kingdom, marking a major change in the country’s approach to smoking policy.

Continue Reading

%

Cinema Chain In Spain Fined €45,000 For Banning Outside Food And Drink

Published

on

cinema-chain-in-spain-fined-e45,000-for-banning-outside-food-and-drink

Consumer groups have argued that cinemas are not primarily food businesses. Photo credit: Capturing Images/Shutterstock

A cinema chain in Algeciras has been fined €45,000 for preventing customers from entering screening rooms with food and drink bought outside the venue, according to reports published on Monday. The sanction was imposed on Yelmo Cines by the Territorial Delegation of Health and Consumer Affairs of the Junta de Andalucía in Cádiz after complaints supported by consumer organisation FACUA. The case concerns the company’s policy of restricting access to customers carrying products purchased elsewhere.

According to the published resolution, the offence was classified as serious under Andalucían consumer protection rules. In the region, serious infringements can carry financial penalties ranging from €10,001 to €100,000.

Basis of the complaint

The dispute centres on whether a cinema whose principal activity is film exhibition can stop customers bringing in food and drink from outside when ticket holders have already paid for entry.

Consumer groups have argued that cinemas are not primarily food businesses and therefore cannot automatically require visitors to buy refreshments on site as a condition of access. They say blanket bans on outside items may place unfair limits on consumer choice. FACUA said it had backed complaints against the practice in several parts of Spain, arguing that customers should be free to decide where they buy snacks and drinks unless there are specific safety or hygiene grounds that justify restrictions.

Previous sanctions

Reports state this is the fourth penalty issued against the Yelmo cine chain over the same issue. Earlier fines cited in coverage include €25,000 in Almería, €12,000 in Sevilla, and €30,000 imposed by the Basque consumer authority Kontsumobide. Those cases also related to restrictions on customers carrying food or drink purchased outside the cinema.

The latest sanction in Algeciras is the highest of the reported fines linked to the practice.

Consumer law background

Spanish consumer law allows regional authorities to investigate business practices and issue penalties where rules are found to have been breached. Enforcement is handled by autonomous communities, meaning cases are decided by regional bodies rather than a single national regulator.

The Algeciras case was handled by the Andalucian administration through its provincial consumer authority in Cádiz. The classification of the offence as serious indicates the authority considered the conduct to go beyond a minor administrative issue, although the published reports do not detail whether aggravating factors were taken into account when setting the amount.

Position of cinemas

Most cinemas sell food and drink as an additional source of income, with popcorn, sweets and beverages forming part of their commercial offer. Some venues have rules limiting what can be taken into screening rooms, particularly where alcohol, hot food or glass containers are concerned. The issue in this case, however, concerns a general ban on products bought elsewhere rather than restrictions linked to safety or disturbance.

No wider industry response had been reported at the time of publication regarding whether operators would review admission policies following the latest fine.

Wider significance

The decision is likely to attract attention beyond Algeciras because similar policies are common in cinemas in Spain and other countries. The case may encourage further complaints from customers or prompt other regional authorities to review existing rules where bans are in place.

It also highlights the role of consumer organisations in bringing complaints that lead to regulatory action. FACUA has previously campaigned on pricing, contract terms and access conditions across several sectors.

What happens next

It was not immediately clear from published reports whether the fine would be appealed. Companies subject to administrative sanctions in Spain can usually challenge decisions through internal procedures and, if necessary, through the courts. Unless overturned or reduced, the penalty adds to a growing number of sanctions issued over the same practice.

For cinema-goers, the ruling does not automatically create a nationwide rule applying to every venue, as enforcement decisions are taken case by case and under regional powers. However, it reinforces the view of several consumer authorities that blanket bans on outside food and drink may breach consumer protection rules when the main service being sold is admission to watch a film. The case is one of the clearest recent examples of regulators intervening in cinema admission policies and may shape how operators approach food and drink rules in future.

Continue Reading

Trending

Copyright © 2017 Spanish Property & News